BioCatalystWatch
SXTPWorkspace / SXTP / OverviewCompany library

60 DEGREES PHARMACEUTICALS, INC.

60 DEGREES PHARMACEUTICALS, INC. (SXTP)

Website

Price
Market cap
Next catalystJan 2027ARAKODA® (tafenoquine) plus standard of care — hospitalized babesiosis · Data readoutCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

ARAKODA® (tafenoquine)ARAKODA® (tafenoquine) plus standard of care — hospitalized babesiosis

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

ARAKODA® (tafenoquine)

PreINDP1P2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

ARAKODA® (tafenoquine)ARAKODA® (tafenoquine) plus standard of care — hospitalized babesiosis

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

ARAKODA® (tafenoquine)

PreINDP1P2P3FilingApproved
Upcoming / outlook

Other pipelines

ARAKODA® (tafenoquine)

Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Approved / commercial

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Operating
Investing
Financing

Reported shares and borrowings

Source and basis

Source and basis

Source and basis

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

SXTP PR & News

PR & News

SXTP SEC archive